Add BrightSurf on Google Email

Enzyme discovery sheds light on vitamin D

Researchers at Queen's University have made a groundbreaking discovery about the breakdown of vitamin D, revealing that changing a single amino acid in the hydroxylase enzyme can alter its pathway. This finding has significant implications for the treatment of cancer and other diseases associated with vitamin D deficiency.

SourceQueen's University·JournalProceedings of the National Academy of Sciences·DateJul 24, 2007

JCI table of contents: November 9, 2006

Scientists have found a way to create smooth muscle cells from adult stem cells using the soluble factors TGF-beta and PDGFB. This breakthrough could lead to new treatments for heart disease by allowing for the creation of healthy tissue. Additionally, researchers have discovered that regulatory T cell populations are impaired in indiv...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 9, 2006

Global view shows strong link between kidney cancer, sunlight exposure

A global study has shown a clear association between kidney cancer incidence rates and proximity to the equator, suggesting that UVB exposure triggers vitamin D production. Countries near the equator have lower kidney cancer rates, while those farther away have higher rates, indicating a potential protective effect of sunlight exposure.

SourceUniversity of California - San Diego·JournalInternational Journal of Cancer·DateSep 18, 2006

Vitamin D supplements should be given to Asian children for two years from birth

Researchers analyze cases of vitamin D deficiency in UK and conclude that supplementing Asian children for two years from birth can curb re-emergence of the deficiency. Vitamin D deficiency is linked to various health problems, including rickets, poor tooth formation, and increased risk of multiple sclerosis and cardiovascular disease.

SourceBMJ Specialty Journals·JournalArchives of Disease in Childhood·DateAug 30, 2006

JCI table of contents, May 11, 2006

Researchers found that the steroid and xenobiotic receptor (SXR) negatively regulates CYP24 expression and subsequent vitamin D breakdown, but can also enhance vitamin D hydroxylation and breakdown by inducing CYP3A4. Additionally, IL-15 administration restored CD4+ T cell production in an animal model of HIV infection, while lithium w...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 11, 2006

A bone of contention in drug-induced osteomalacia

Researchers found that SXR inhibits VDR-mediated CYP24 activity in mice, contradicting previous studies. In humans, rifampicin treatment increases CYP3A4 expression but has no effect on CYP24 expression, suggesting a complex regulatory mechanism.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 11, 2006